Oramed Pharmaceuticals annual revenue
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Oramed Pharmaceuticals Revenue Growth & History (ORMP)
Oramed Pharmaceuticals reported $2.0M in revenue for fiscal 2025.
View full Oramed Pharmaceuticals company overviewOramed Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.0M | $2.0M | — |
| 2024 | 2024-12-31 | $0 | −$1.3M | −100.00% |
| 2023 | 2023-12-31 | $1.3M | −$1.4M | −50.43% |
| 2022 | 2022-12-31 | $2.7M | — | — |
| 2021 | 2021-08-31 | $2.7M | −$7,000 | −0.26% |
| 2020 | 2020-08-31 | $2.7M | $7,000 | +0.26% |
| 2019 | 2019-08-31 | $2.7M | $254,000 | +10.37% |
| 2018 | 2018-08-31 | $2.4M | −$7,000 | −0.29% |
| 2017 | 2017-08-31 | $2.5M | $1.8M | +283.15% |
| 2016 | 2016-08-31 | $641,000 | — | — |
Oramed Pharmaceuticals quarterly revenue
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q1.21
Q2.21
Q2.21
Q3.21
Q3.21
Q3.22
Q1.22
Q1.22
Q2.22
Q3.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | −$2.0M | −100.00% |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $2.0M | — | — |
| Q4 2023 | 2023-12-31 | $0 | −$681,000 | −100.00% |
| Q3 2023 | 2023-09-30 | $0 | −$682,000 | −100.00% |
| Q2 2023 | 2023-06-30 | $674,000 | $0 | 0.00% |
| Q1 2023 | 2023-03-31 | $666,000 | $0 | 0.00% |
| Q4 2022 | 2022-12-31 | $681,000 | $451,000 | +196.09% |
| Q3 2022 · Sep 30 | 2022-09-30 | $682,000 | $0 | 0.00% |
| Q3 2022 · Jun 30 | 2022-06-30 | $674,000 | $0 | 0.00% |
| Q2 2022 | 2022-03-31 | $666,000 | $0 | 0.00% |
| Q1 2022 · Dec 31 | 2021-12-31 | $230,000 | $0 | 0.00% |
| Q1 2022 · Nov 30 | 2021-11-30 | $674,000 | $0 | 0.00% |
| Q3 2022 · Sep 30 | 2021-09-30 | $682,000 | — | — |
| Q3 2021 · Jun 30 | 2021-06-30 | $674,000 | — | — |
| Q3 2021 · May 31 | 2021-05-31 | $681,000 | $0 | 0.00% |
| Q2 2021 · Mar 31 | 2021-03-31 | $666,000 | — | — |
| Q2 2021 · Feb 28 | 2021-02-28 | $665,000 | −$9,000 | −1.34% |
| Q1 2021 · Dec 31 | 2020-12-31 | $230,000 | — | — |
| Q1 2021 · Nov 30 | 2020-11-30 | $674,000 | $0 | 0.00% |
| Q4 2020 | 2020-08-31 | $681,000 | $0 | 0.00% |
| Q3 2020 | 2020-05-31 | $681,000 | −$1,000 | −0.15% |
| Q2 2020 | 2020-02-29 | $674,000 | $8,000 | +1.20% |
| Q1 2020 | 2019-11-30 | $674,000 | $0 | 0.00% |
| Q4 2019 | 2019-08-31 | $681,000 | $64,000 | +10.37% |
| Q3 2019 | 2019-05-31 | $682,000 | $65,000 | +10.53% |
| Q2 2019 | 2019-02-28 | $666,000 | $62,000 | +10.26% |
| Q1 2019 | 2018-11-30 | $674,000 | $63,000 | +10.31% |
| Q4 2018 | 2018-08-31 | $617,000 | −$1,000 | −0.16% |
| Q3 2018 | 2018-05-31 | $617,000 | $0 | 0.00% |
| Q2 2018 | 2018-02-28 | $604,000 | −$7,000 | −1.15% |
| Q1 2018 | 2017-11-30 | $611,000 | $1,000 | +0.16% |
| Q4 2017 | 2017-08-31 | $618,000 | — | — |
| Q3 2017 | 2017-05-31 | $617,000 | $780,000 | +478.53% |
| Q2 2017 | 2017-02-28 | $611,000 | $486,000 | +388.80% |
| Q1 2017 | 2016-11-30 | $610,000 | — | — |
| Q3 2016 | 2016-05-31 | −$163,000 | — | — |
| Q2 2016 | 2016-02-29 | $125,000 | — | — |
Oramed Pharmaceuticals revenue growth trends
Oramed Pharmaceuticals's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Oramed Pharmaceuticals source filings ↗